Amylyx Pharmaceuticals Announces $350 Million Proposed Public Offering Of Common Stock
AMLX•Proposed public offering
Aug. 18 (Reuters) - Amylyx Pharmaceuticals, Inc. (AMLX.O):
- Amylyx Pharmaceuticals announces a $350.0 million proposed public offering of common stock.
- The company said the proceeds will fund avexitide pre-commercial activities, research and development, and general corporate purposes.
Source text: ID:nBwbJf7spa
